Global Beta Blockers Market Size 2024, Forecast To 2033

6 Mar, 2024

The beta blockers market size has grown strongly in recent years. It will grow from $9.16 billion in 2023 to $9.78 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to hypertension management, treatment of cardiovascular diseases, post-myocardial infarction care, migraine prophylaxis, management of anxiety and tremors. The beta blockers market size is expected to see strong growth in the next few years. It will grow to $12.28 billion in 2028 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to prevalence of cardiovascular diseases, expanded applications in heart failure, combination therapies, focus on hypertension guidelines, exploration of novel indications. Major trends in the forecast period include application in anxiety and performance situations, potential neuroprotective effects, individualized treatment approaches, impact of generic versions, integration with digital health platforms.

Global Beta Blockers Market Key Driver

The rise in the incidence of cardiovascular diseases is set to propel the growth of the beta blockers market in the coming years. Cardiovascular diseases (CVDs) encompass a range of disorders affecting the heart and blood vessels, often attributed to unhealthy lifestyles, poor dietary habits, lack of physical activity, tobacco usage, and obesity. Beta blockers serve as key therapeutic agents, exerting beneficial effects on heart function and blood vessels, thereby reducing the incidence and severity of cardiovascular events. Data from the National Health Survey 2020-21 conducted by the Australian Bureau of Statistics revealed an estimated 571,000 Australians aged 18 and above, constituting 2.9% of the adult population, living with coronary heart disease (CHD) in 2020-21. This surge in cardiovascular diseases underscores the pivotal role of beta blockers in mitigating risks and managing conditions, thereby driving the growth of the market. Hence, the rise in the incidence of cardiovascular diseases is expected to fuel the expansion of the beta blockers market by 2028.

Get A Free Sample Of The Global Beta Blockers Market Report

Global Beta Blockers Market Segments

The beta blockers market covered in this report is segmented –
1) By Type: Non-selective Agents, Selective Agents
2) By Indication: Angina Pectoris, Heart Failure, High Blood Pressure, Other Indications
3) By Drugs: Betaxolol, Acebutolol, Esmolol, Other Drugs
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By Application: Cardiac Diseases, Hypertension, Glaucoma, Other Applications
By Geography:The regions covered in the beta blockers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain North America was the largest region in the beta blockers market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global beta-blockers market report during the forecast period. The regions covered in the beta blockers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Major Beta Blockers Industry Players

Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca plc, Johnson and Johnson, Eli Lilly and Company, Sanofi SA, Bristol-Myers Squibb Company, Bayer AG, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Abbott Laboratories, Eagle Pharmaceuticals Inc., Neon Healthcare Ltd., Midas Pharma GmbH, Global Calcium PVT. LTD., AbbVie Inc., Mylan N.V., Boehringer Ingelheim International GmbH, Aspen Pharmacare Holdings Limited, Lupin Limited, Torrent Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Sandoz International GmbH, Wockhardt Ltd., Endo Pharmaceuticals Inc., Apotex Inc.

Get The Full Global Beta Blockers Market Report

Beta Blockers Market Overview

Beta blockers also known as beta-adrenergic blocking agents, are a class of medications commonly used to treat various cardiovascular conditions by decreasing the activity of the heart. It is commonly prescribed for blood pressure control, angina, heart failure, and a few cardiac rhythm abnormalities.

Beta Blockers Global Market Report 2023 provides data on the global beta blockers market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The beta blockers market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.